Xyzal and Basaglar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xyzal (levocetirizine dihydrochloride) and Basaglar (insulin glargine). Common drug interactions include back pain among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Xyzal and Basaglar. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Xyzal?

Xyzal has active ingredients of levocetirizine dihydrochloride. It is often used in allergies. eHealthMe is studying from 21,479 Xyzal users. Check the latest studies of Xyzal.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

On Jul, 12, 2026

14 people who take Xyzal and Basaglar together, and have interactions are studied.

What are the common drug interactions of Xyzal and Basaglar, by gender? *:

female:

Back pain
Drug ineffective
Headache (pain in head)
Eye pain
Infusion related reaction
Insomnia (sleeplessness)
Muscle spasms (muscle contraction)

male:

Anaemia (lack of blood)
Cardiac failure congestive
Wound dehiscence (a surgical incision reopens either internally or externally)
Drug ineffective
Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
Hepatic enzyme increased
Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
Muscle spasms (muscle contraction)
Narcolepsy (brain's inability to regulate sleep-wake cycles normally)
Restless legs syndrome (a powerful urge to move your legs)

What are the common drug interactions of Xyzal and Basaglar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Drug ineffective
Blood glucose increased
Oedema (fluid collection in tissue)

50-59:

Anaemia (lack of blood)
Cardiac failure congestive
Wound dehiscence (a surgical incision reopens either internally or externally)
Chronic kidney disease
Cor pulmonale acute (rapid enlargement of the right ventricle of the heart)
Cutaneous vasculitis (an inflammatory process affecting the vessel wall that leads to its damage)
Decreased appetite
Pulmonary embolism (blockage of the main artery of the lung)
Respiratory failure (inadequate gas exchange by the respiratory system)
Staphylococcal infection (an infection with staphylococcus bacteria)

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 28.57%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 28.57%
Renal Cell Carcinoma (a kidney cancer): 3 people, 21.43%
Metastasis (spreadable cancer to other organ from origin): 3 people, 21.43%
Immunodeficiency Common Variable: 2 people, 14.29%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 1 person, 7.14%
Hypersensitivity: 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Diabetes: 1 person, 7.14%
Cushing's Syndrome (obesity, a rounded face, increased fat): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Xyzal and Basaglar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously